Table. 3.
Table. 3.
Functional gastrointestinal disorders (FGIDs): characteristics of selected clinical trials included in the review
| Reference | Type of study | Clinical setting/population | Sample size | Age (year) | Daily dose | Probiotic species | Duration of intervention (weeks) | System | Main outcomes |
|---|---|---|---|---|---|---|---|---|---|
| Ringel-Kulka et al., 2011 (USA) | RCT | Functional bowel disorders | 60 | 18-65 Mean age Int: 36 Plac: 37 | Twice a day (2×1011 CFU CFU/d) | 8 | IBS-QoL | Positive effect |
RCT, randomized control trial; CFU, colony forming unit; IBS-QoL, irritable bowel syndrome-quality of life; Int, intervention; Plac, placebo.
Prev Nutr Food Sci 2024;29:237~255 https://doi.org/10.3746/pnf.2024.29.3.237
© Prev. Nutr. Food Sci.